Current Neuro-Oncology

Volume 25 Number 24
31 December 2023

Home > Publications > Current Neuro-Oncology > Volume 25, Year 2023 > Number 24, 31 December

Buckner-Wolfson E, Jung G, Kim T, Fatemi R, Liriano G, Dalvi N, Behbahani M, Chin S, Martin A, Kobets A.
A Case Report of Infant-type Hemispheric Glioma with a Novel GAB1-ABL2 Kinase Fusion Treated with Dasatinib.
Pediatr Neurosurg. 2023 Dec 18. doi: 10.1159/000535842. PMID: 38109857. Case report.

Garcia CA, Suárez-Meade P, Brooks M, Bhargav AG, Freeman ML, Harvey LM, Quinn J, Quiñones-Hinojosa A.
Behavior of glioblastoma brain tumor stem cells following a suborbital rocket flight: reaching the "edge" of outer space.
NPJ Microgravity. 2023 Dec 18;9(1):92. doi: 10.1038/s41526-023-00341-9. PMID: 38110398. Laboratory investigation.

Le Rhun E, Gorlia T, Felsberg J, Jongen J, Maurage CA, Ducray F, Gramatzki D, Hau P, Chinot OL, Preusser M, Cartalat S, Roth P, van den Bent M, Furtner J, Collienne M, Reifenberger G, Weller M.
Zotiraciclib (TG02) for newly diagnosed glioblastoma in the elderly or for recurrent glioblastoma: The EORTC 1608 STEAM trial.
Eur J Cancer. 2023 Dec 18;198:113475. doi: 10.1016/j.ejca.2023.113475. PMID: 38159337. Interventional study. ˍ

Sato D, Takami H, Tanaka S, Takayanagi S, Ikemura M, Saito N.
Long-term survival after cordectomy in a case of spinal cord diffuse midline glioma, H3K27-altered: illustrative case.
J Neurosurg Case Lessons. 2023 Dec 18;6(25):CASE23296. doi: 10.3171/CASE23296. PMID: 38109730. Case report.

Spiekman IAC, Geurts BS, Zeverijn LJ, de Wit GF, van der Noort V, Roepman P, de Leng WWJ, Jansen AML, Kusters B, Beerepoot LV, de Vos FYFL, de Groot DA, de Groot JWB, Hoeben A, Buter J, Gelderblom HAJ, Voest EE, Verheul HMW.
Efficacy and Safety of Panitumumab in Patients With RAF/RAS-Wild-Type Glioblastoma: Results From the Drug Rediscovery Protocol.
Oncologist. 2023 Dec 18:oyad320. doi: 10.1093/oncolo/oyad320. PMID: 38109296. Interventional study.


Brighi C, Waddington DEJ, Keall PJ, Booth J, O'Brien K, Silvester S, Parkinson J, Mueller M, Yim J, Bailey DL, Back M, Drummond J.
The MANGO study: a prospective investigation of oxygen enhanced and blood-oxygen level dependent MRI as imaging biomarkers of hypoxia in glioblastoma.
Front Oncol. 2023 Dec 19;13:1306164. doi: 10.3389/fonc.2023.1306164. PMID: 38192626. Interventional study. ˍ


Li A, Hancock JC, Quezado M, Ahn S, Briceno N, Celiku O, Ranjan S, Aboud O, Colwell N, Kim SA, Nduom E, Kuhn S, Park DM, Vera E, Aldape K, Armstrong TS, Gilbert MR.
TGF-β and BMP signaling are associated with the transformation of glioblastoma to gliosarcoma and then osteosarcoma.
Neurooncol Adv. 2023 Dec 19;6(1):vdad164. doi: 10.1093/noajnl/vdad164. PMID: 38292240. Case report. ˍ

Pourhadi N, Meaidi A, Friis S, Torp-Pedersen C, Mørch LS.
Menopausal hormone therapy and central nervous system tumors: Danish nested case-control study.
PLoS Med. 2023 Dec 19;20(12):e1004321. doi: 10.1371/journal.pmed.1004321. PMID: 38113227. Observational study.

Wimberly CE, Gulrajani NB, Russ JB, Landi D, Wiemels JL, Towry L, Wiencke JK, Walsh KM.
Maternal prenatal use of alcohol, tobacco, and illicit drugs and associations with childhood cancer subtypes.
Cancer Epidemiol Biomarkers Prev. 2023 Dec 19. doi: 10.1158/1055-9965.EPI-23-1027. PMID: 38112788. Observational study˰

Kinslow CJ, Siegelin MD, Iwamoto FM, Gallitto M, Neugut AI, Yu JB, Cheng SK, Wang TJC.
MGMT promoter methylation in 1p19q-intact gliomas.
J Neurooncol. 2023 Dec 20. doi: 10.1007/s11060-023-04515-z. PMID: 38114801. Observational study˰

Doniselli FM, Pascuzzo R, Agrò M, Aquino D, Anghileri E, Farinotti M, Pollo B, Paterra R, Cuccarini V, Moscatelli M, DiMeco F, Sconfienza LM.
Development of A Radiomic Model for MGMTPromoter Methylation Detection in Glioblastoma Using Conventional MRI.
Int J Mol Sci. 2023 Dec 21;25(1):138. doi: 10.3390/ijms25010138. PMID: 38203308. Observational study. ˍ

Kim N, Shin H, Lim DH, Nam DH, Lee JI, Seol HJ, Kong DS, Choi JW, Chong K, Lee WJ.
Treatment Outcomes after Dose-Escalated Moderately Hypofractionated Radiotherapy for Frail Patients with High-Grade Glioma.
Cancers (Basel). 2023 Dec 21;16(1):64. doi: 10.3390/cancers16010064. PMID: 38201492. Observational study. ˍ

Baudou E, Peran P, Tensaouti F, Arribarat G, Pariente J, Courbieres N, Pollidoro L, Bertozzi AI, Gambart M, Sevely A, Roques M, Ducassou A, Danna J, Tallet J, Dufour C, Chaix Y, Laprie A.
The long-term impact of irradiation on functional connectivity in brain circuits involved in memory processes after pediatric posterior fossa tumor.
Radiother Oncol. 2023 Dec 23:110073. doi: 10.1016/j.radonc.2023.110073. PMID: 38145791. Interventional study˰

Bao H, Ai S, Wang G, Yi L, Lai J, Wang S, Lv Z, Li C, Liu Q, Zhao X, Wu C, Liu C, Mi S, Sun X, Hao C, Liang P.
Intraoperative radiotherapy in recurrent IDH-wildtype glioblastoma with gross total resection: A single-center retrospective study.
Clin Neurol Neurosurg. 2023 Dec 26;236:108103. doi: 10.1016/j.clineuro.2023.108103. PMID: 38199118. Observational study˰ ˍ


Gately L, Mesía C, Sepúlveda JM, Del Barco S, Pineda E, Gironés R, Fuster J, Hong W, Dumas M, Gill S, Navarro LM, Herrero A, Dowling A, de Las Peñas R, Vaz MA, Alonso M, Lwin Z, Harrup R, Peralta S, Long A, Perez-Segura P, Ahern E, Garate CO, Wong M, Campbell R, Cuff K, Jennens R, Gallego O, Underhill C, Martinez-Garcia M, Covela M, Cooper A, Brown S, Rosenthal M, Torres J, Collins IM, Gibbs P, Balana C.
A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma.
J Neurooncol. 2023 Dec 28. doi: 10.1007/s11060-023-04513-1. PMID: 38153582. Interventional study˰

Kesarwani R, Singh A, Aqueel M, Singh V, Prakash G.
A Comparative Retrospective Survival Analysis Study of Brain Tumor Patients in Age Less Than or Equal to 50 Years versus More Than 50 Years of Age.
Asian J Neurosurg. 2023 Dec 29;18(4):777-781. doi: 10.1055/s-0043-1777271. PMID: 38161610. Observational study. ˍ

DesJarlais AM, Miller R, Ali AS, Niazi MZ, Cappelli L, Glass J, Farrell CJ, Shi W.
Case report: durable response of gliomatosis cerebri with concurrent tumor-treating fields (TTFields) and chemoradiotherapy treatment.
Chin Clin Oncol. 2023 Dec 31;12(6):69. doi: 10.21037/cco-23-114. PMID: 38195076. Case report. ˍ

Zhang F, Cheng L, Ding Z, Wang S, Zhao X, Zhao Z, Liang C, Wu K, Zhang D, Wang Y, Fan T.
Does H3K27M Mutation Impact Survival Outcome of High-Grade Spinal Cord Astrocytoma?
Neurospine. 2023 Dec 31;20(4):1480-1489. doi: 10.14245/ns.2346650.325. PMID: 38171314. Observational study. ˍ